|
Re: Trying to be realistic here
|
4
|
Resverlogix Corp.
|
Mar 25, 2020 10:26AM
|
|
Re: All quiet on the western front
|
4
|
Resverlogix Corp.
|
Jan 03, 2020 03:21PM
|
|
Re: " Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
|
4
|
Resverlogix Corp.
|
May 09, 2022 09:13AM
|
|
Scoring
|
4
|
Resverlogix Corp.
|
Jun 14, 2021 09:59AM
|
|
Re: Hepalink
|
4
|
Resverlogix Corp.
|
Mar 02, 2020 09:14AM
|
|
Re: Disease X
|
4
|
Resverlogix Corp.
|
Jan 22, 2024 09:54AM
|
|
Re: FUD!
|
4
|
Resverlogix Corp.
|
Oct 13, 2019 12:54PM
|
|
I know a few are either playing or following TRIL/Trillium Theraperutics
|
4
|
Resverlogix Corp.
|
Mar 02, 2020 09:22AM
|
|
bit odd to see Hepalink continue to hit new...
|
4
|
Resverlogix Corp.
|
Nov 11, 2019 09:45AM
|
|
Re: Was just reading the hepa release again from June 29th
|
4
|
Resverlogix Corp.
|
Jul 12, 2020 10:51PM
|
|
Trying to understand this NR?
|
4
|
Resverlogix Corp.
|
May 09, 2022 10:31AM
|
|
guesses koo & albclip?
|
4
|
Resverlogix Corp.
|
Oct 16, 2019 03:09PM
|
|
Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 07:21AM
|
|
I sent this to IR in regard to this statement below i received:then their response ...
|
4
|
Resverlogix Corp.
|
Sep 21, 2022 09:27PM
|
|
Re: got this & sent a response/follow up minutes before …
|
4
|
Zenith Epigenetics
|
Dec 19, 2023 02:22PM
|
|
Bouncing off the 52 week low..
|
4
|
Resverlogix Corp.
|
Aug 25, 2023 10:07AM
|
|
Re: Question re BOD votes
|
4
|
Resverlogix Corp.
|
Jun 27, 2022 04:22PM
|
|
Re: Goldman Sachs
|
4
|
Resverlogix Corp.
|
Sep 19, 2019 01:44PM
|
|
Re: My hope is
|
4
|
Zenith Epigenetics
|
Nov 05, 2023 08:56AM
|
|
Re: Positives vs. negatives
|
4
|
Resverlogix Corp.
|
Nov 20, 2019 01:14PM
|
